| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANAPC1
|
anaphase promoting complex subunit 1
|
|
AR
|
androgen receptor
|
|
ATM
|
ATM serine/threonine kinase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCR
|
breakpoint cluster region
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CAND1
|
cullin-associated and neddylation-dissociated 1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CKS1BP7
|
CDC28 protein kinase regulatory subunit 1B pseudogene 7
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
CTTN
|
cortactin
|
|
CUL1
|
cullin 1
|
|
CUL3
|
cullin 3
|
|
CUL4A
|
cullin 4A
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
E2F1
|
E2F transcription factor 1
|
|
EP300
|
E1A binding protein p300
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
FBXO31
|
F-box protein 31
|
|
FBXO5
|
F-box protein 5
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FZR1
|
fizzy/cell division cycle 20 related 1 (Drosophila)
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HDAC3
|
histone deacetylase 3
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL16
|
interleukin 16
|
|
IL2
|
interleukin 2
|
|
ING4
|
inhibitor of growth family, member 4
|
|
KAT8
|
K(lysine) acetyltransferase 8
|
|
KIF14
|
kinesin family member 14
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
PHB2
|
prohibitin 2
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRKCI
|
protein kinase C, iota
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
RAG2
|
recombination activating gene 2
|
|
RB1
|
retinoblastoma 1
|
|
RBL1
|
retinoblastoma-like 1
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RHOA
|
ras homolog family member A
|
|
RND3
|
Rho family GTPase 3
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SKP1
|
S-phase kinase-associated protein 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SMAD7
|
SMAD family member 7
|
|
SP1
|
Sp1 transcription factor
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TP53
|
tumor protein p53
|
|
TSC2
|
tuberous sclerosis 2
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WIF1
|
WNT inhibitory factor 1
|